As expected in our study, SJT reduced the levels of IL-1β, IL-6, and TNF-α in the serum of AIA rats, indicating SJT could suppress RA by modulating the inflammation-related pathways, which were also predicted in the follow-up study by network pharmacological approach. Here, IL1B is linked to rheumatoid arthritis.